Comparison of Hemostatic Matrix & Bipolar Coagulation in Surgical

Status Completed

Clinical Trial Summary

In this study, impacts of hemostatic matrix and bipolar electrocoagulation on ovarian reserve in women undergoing ovarian endometrioma excision are compared.

Clinical Trial Description

Endometriosis is defined as the existence of endometrial tissue outside of the uterine cavity. Ovaries are the most common effected sites and the disease causes endometriotic cysts in the ovaries. The treatment of endometriomas is still highly controversial. It is well known that the ovarian reserve is compromised as a result of endometriomas. Even though a variety of medical agents can be used to treat endometriomas, when endometriomas cause pelvic pain or infertility especially when they are > 4cm in size, surgical treatment can be offered. Even though there is no standard surgical treatment removal of cyst wall is usually the preferred method. Aspiration of cyst fluid and coagulation of the cyst wall have been practiced, however are associated with more recurrences.

Nevertheless, the impact of surgical treatment on ovarian reserve has not been clarified. There are mainly two types of ovarian injury during surgical removal of endometriomas. First, there is risk that the healthy ovarian tissue can be removed along with the cyst wall. Second, there is risk of of thermal injury that occurs after cyst removal during hemostasis by electrocoagulation.

By this context, investigating an alternative method to electrocautery which causes less thermal injury to ovary would open a new strategy in the treatment of infertile patients with endometrioma.

A new method "hemostatic matrix" has been developed to provide hemostasis. Endometriomas can be treated without thermal injury to healthy ovarian tissue using this method compared to bipolar coagulation.

In the literature, there is no controlled randomized study compared hemostatic matrix and bipolar coagulation for impact on ovarian reserve after treatment ovarian endometriomas.

There are two main principles when treating endometriomas. First, recurrence should not occur, and the second is minimal ovarian injury.

On the backgrounds of this philosophy, it can be hypothesized that hemostatic matrix can cause less damage to ovarian tissue compared to classical bipolar coagulation. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01268930
Study type	Interventional
Source	Ankara University
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	March 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05323539` - Comparison of Thyroid Volumes in Patients With and Without Endometrioma	N/A
Recruiting	`NCT04178876` - Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)	N/A
Recruiting	`NCT04151433` - Conservative Endometrioma Surgery	N/A
Completed	`NCT01942122` - DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis	Phase 2/Phase 3
Withdrawn	`NCT00999479` - Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation	N/A
Recruiting	`NCT03687398` - Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls
Not yet recruiting	`NCT06377553` - PET/MRI for Evaluation of Endometriosis
Not yet recruiting	`NCT03788720` - Suture of the Ovary After Enucleation of Ovarian Endometrioma	N/A
Completed	`NCT01982526` - Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
Recruiting	`NCT05962775` - Ethanol Sclerotherapy Prior to ART	N/A
Completed	`NCT03484546` - Optimum Menstrual Cycle Time for Endometrioma Excision
Completed	`NCT01808170` - Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve	N/A
Recruiting	`NCT05637073` - Effect of Management of the Endometrioma on Ovarian Reserve
Completed	`NCT06219044` - Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization	N/A
Recruiting	`NCT03620838` - Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
Terminated	`NCT03571776` - Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial	N/A
Enrolling by invitation	`NCT02472873` - Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas	N/A
Completed	`NCT04941833` - Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo	Phase 2/Phase 3
Completed	`NCT06274086` - Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma	N/A
Not yet recruiting	`NCT04452123` - Endometrioma Treatment and Ovarian Function	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms